Weigang Dong

Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Efficacy and challenges of immunotherapy in advanced EGFR-mutant NSCLC: a case report.

Efficacy and challenges of immunotherapy in advanced EGFR-mutant NSCLC: a case report.

Journal: Frontiers in oncology

Published: April 03, 2026

Fatal AA-like bone marrow failure and invasive pulmonary aspergillosis after long-term pembrolizumab in squamous NSCLC: a case report.

Fatal AA-like bone marrow failure and invasive pulmonary aspergillosis after long-term pembrolizumab in squamous NSCLC: a case report.

Journal: Frontiers in immunology

Published: January 31, 2026

Impact of chronic obstructive pulmonary disease on the efficacy and safety of neoadjuvant immune checkpoint inhibitors combined with chemotherapy for resectable non-small cell lung cancer: a retrospective cohort study.

Impact of chronic obstructive pulmonary disease on the efficacy and safety of neoadjuvant immune checkpoint inhibitors combined with chemotherapy for resectable non-small cell lung cancer: a retrospective cohort study.

Journal: BMC cancer

Published: November 04, 2023

Efficacy and safety of pembrolizumab as first-line treatment for advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease: protocol for a prospective, single-arm, single-center, phase II clinical trial.

Efficacy and safety of pembrolizumab as first-line treatment for advanced non-small cell lung cancer complicated with chronic obstructive pulmonary disease: protocol for a prospective, single-arm, single-center, phase II clinical trial.

Journal: Frontiers in oncology

Published: March 03, 2023

Catechin regulates miR-182/GGPPS1 signaling pathway and inhibits LPS-induced acute lung injury in mice.

Catechin regulates miR-182/GGPPS1 signaling pathway and inhibits LPS-induced acute lung injury in mice.

Journal: Immunopharmacology and immunotoxicology

Published: November 30, 2021

Impact of severe-to-very severe chronic obstructive pulmonary disease on the prognosis of patients with non-small cell lung cancer who received chemotherapy.

Impact of severe-to-very severe chronic obstructive pulmonary disease on the prognosis of patients with non-small cell lung cancer who received chemotherapy.

Journal: The clinical respiratory journal

Published: June 17, 2019

Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD.

Impact of chemotherapy in the prognosis of non-small-cell lung cancer patients with severe to very severe COPD.

Journal: International journal of chronic obstructive pulmonary disease

Published: December 13, 2018

Association between features of COPD and risk of venous thromboembolism.

Association between features of COPD and risk of venous thromboembolism.

Journal: The clinical respiratory journal

Published: December 06, 2018

Showing 1-8 of 8

Last Updated: 09/26/2026